Figure 2. Increased vascular
endothelial cell count in eyes with proliferative diabetic
retinopathy (PDR) was suppressed by pretreatment of intravitreal
bevacizumab (IVB). The epiretinal membranes of proliferative
vitreoretinopathy (PVR) eyes were set as the control group.
Quantitative analysis for the vascular endothelial cell count in
the neovascular membranes (NVMs) of PDR eyes and epiretinal
membranes of PVR eyes was determined by counting positively
stained cells in 10 representative fields. Each value represents
means±SEM from three independent experiments (p=0.003).